Tuesday,April 20, 2021
Beta Version

Iranian-Cuban COVID-19 Vaccine to Undergo Phase 3 of Human Trial

2021-03-01 14:36:42
Iran’s Coronavirus Headquarters says the phase three of the human trial of a COVID-19 vaccine jointly developed by the Pasteur Institute of Iran and Cuba will get underway in three weeks’ time.

Some 50,000 people will receive the jab in this phase, said Alireza Raisi, the spokesman for the headquarters.

“Between two and four million doses of the vaccine will be produced by April 2021, and this is the first Iranian [coronavirus] vaccine administered,” he added. 

He noted that the vaccination will take place in accordance with the priorities set by the Coronavirus Headquarters.

Raisi said the elderly, the disabled and medical personnel are among the first to be inoculated.

Tags:
Sharing:
Rss

GOVERNMENT OF THE ISLAMIC REPUBLIC OF IRAN